Physician profile
Michael R Hand
NPI 1417927492
$656.77
in general payments reported to CMS, 2019-2025
16 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $60.24 · 2021: $71.56 · 2022: $94.46 · 2023: $21.26 · 2024: $109 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219 · Education: $55.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.35 |
| Education | $55.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $142.70 | 2019-2025 | Tavneos |
| Fresenius USA Marketing, INC. | $75.15 | 2020-2024 | Velphoro |
| Opko Pharmaceuticals, LLC | $65.45 | 2019-2025 | Rayaldee |
| Astrazeneca Pharmaceuticals LP | $62.35 | 2021-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.97 | 2024-2025 | Jardiance |
| Vifor Pharma, INC. | $42.38 | 2022 | |
| Novo Nordisk INC | $34.48 | 2025 | Ozempic, Rybelsus |
| Travere Therapeutics, INC. | $29.34 | 2025 | Filspari |
| Otsuka America Pharmaceutical, INC. | $28.31 | 2020 | |
| Medtronic, INC. | $21.69 | 2022 | |
| Mallinckrodt Hospital Products INC. | $21.63 | 2024 | Acthar |
| Glaxosmithkline, LLC. | $20.23 | 2020 | |
| Shire North American Group INC | $18.91 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.24 | 2025 | |
| Janssen Pharmaceuticals, INC | $16.51 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argon Medical Devices, INC. | $16.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.